Table 4.
Medications during hospitalization and postdischarge for abdominal abscess.
| Total (n = 99) | PO Antibiotics (n = 74) | IV Antibiotics (n = 25) | P | |
|---|---|---|---|---|
| Hospitalization Antibiotics (n, %) | ||||
| Fluoroquinolones | 44 (44) | 37 (50) | 7 (28) | .05 |
| Metronidazole | 66 (67) | 53 (72) | 13 (52) | .06 |
| Penicillins +/- beta-lactamase inhibitors | 34 (34) | 22 (30) | 12 (48) | .11 |
| Cephalosporins | 25 (25) | 17 (23) | 8 (32) | .39 |
| Carbapenems | 8 (8) | 2 (3) | 6 (24) | <.01 |
| Lipopeptides | 0 (0) | 0 (0) | 0 (0) | |
| Glycopeptides | 7 (7) | 4 (5) | 3 (12) | .28 |
| Aminoglycosides | 2 (2) | 0 (0) | 2 (8) | .02 |
| Postdischarge Antibiotics (n, %) | ||||
| Fluoroquinolones | 51 (52) | 50 (68) | 1 (4) | <.01 |
| Metronidazole | 72 (73) | 59 (80) | 13 (52) | <.01 |
| Lincosamides | 3 (3) | 3 (3) | 0 (0) | .31 |
| Pencillins +/- beta-lactamase inhibitors | 18 (18) | 11 (15) | 7 (28) | .14 |
| Cephalosporins | 21 (21) | 13 (18) | 8 (32) | .13 |
| Carbapenems | 8 (8) | 0 (0) | 8 (32) | <.01 |
| Glycopeptides | 2 (2) | 2 (3) | 0 (0) | .41 |
| Medications within 6 months of discharge (n, %) | ||||
| Steroids | 39 (39) | 30 (41) | 9 (36) | .69 |
| 5-aminosalicylic acid | 11 (11) | 7 (10) | 4 (16) | .37 |
| Immunomodulators | 18 (18) | 14 (19) | 4 (16) | .74 |
| Anti-TNF | 39 (39) | 30 (41) | 9 (36) | .69 |
| Combination Anti-TNF/immunomodulator | 8 (8) | 6 (8) | 2 (8) | .99 |
| Anti-Integrin | 3 (3) | 3 (4) | 0 (0) | .31 |
| Anti-IL 12/23 | 4 (4) | 4 (5) | 0 (0) | .24 |